Loading ...
Sorry, an error occurred while loading the content.
 

SHAC group moving in from England?

Expand Messages
  • gregoire525
    NATIONAL NEWS: US is the export target for animal rights militants By Patrick Jenkins Financial Times; Aug 14, 2002 The animalrights militants who came near to
    Message 1 of 1 , Aug 22, 2002
      NATIONAL NEWS: US is the export target for animal rights militants
      By Patrick Jenkins
      Financial Times; Aug 14, 2002

      The animalrights militants who came near to closing Huntingdon Life
      Sciences, the drug-testing group, are proving increasingly adept at
      exporting their brand of terror tactics to the US.

      When Marsh, the broking arm of Marsh & McLennan, biggest insurance
      broker in the world, called recently on security experts to protect
      the company from an intensifying campaign on both sides of the
      Atlantic, it showed the US establishment was getting worried.

      Little wonder. In recent months, activists have lobbied banks about
      their choice of customers and fast-food chains about their treatment
      of chickens.

      "Things have really changed here over the past few years," says
      Ingrid Newkirk, the British-born president of one of the biggest US
      campaign groups, People for the Ethical Treatment of Animals. "There
      are now thousands of activists regularly displaying the public's
      outrage at the way companies use animals."

      Increasingly, they are using a British protester tactic. Rather than
      waving banners and chanting slogans outside their target's offices,
      they stage direct - sometimes violent - disruptive action against
      secondary organisations, frequently the financial institutions that
      underpin the core butt of the protest.

      Marsh has been singled out because it is alleged to have brokered
      insurance for Huntingdon. Activists have vandalised directors' cars
      and thrown bricks through their house windows.

      It is three years since Stop Huntingdon Animal Cruelty, began its
      campaign after the company was accused of mistreating the animals in
      its laboratories.

      Activism intensified last year, with a baseball bat beating of Brian
      Cass, its chief executive, in Britain and threats delivered to
      secondary targets - stockbrokers and marketmakers who dealt in
      Huntingdon shares and banks who lent the company money.

      "We realised HLS needed its customers and all the other companies
      that supported it. But those companies didn't need HLS," says Greg
      Avery, Shac's chief co-ordinator.

      Shac claimed a victory at the end of last year when Huntingdon
      relocated its head office to the US, using Maryland's more secretive
      company law to protect its directors, shareholders and financial
      backers from public disclosure - and, it hoped, from attack.
      Instead, protests - now organised on a transatlantic scale -
      intensified, orchestrated in the US by Kevin Jonas, an American who
      learned his activism in the UK.

      Stephens Group, Huntingdon's biggest and most outspoken financial
      backer, based in Little Rock, Arkansas, ignominiously withdrew its
      support in January. During that offensive, Shac employed another
      tactic - "tertiary targeting" - campaigning against Bank of America,
      one of Stephens' most important customers.

      Frankie Trull, president of the US Foundation for Biomedical
      Research, says: "This is a very dangerous precedent to set. I'm
      concerned that it's the tip of the proverbial iceberg."

      With an estimated 2m-plus animal rights supporters now in the US, Ms
      Trull is concerned that corporate America is not prepared for
      becoming secondary targets if Shac-style activism is adopted by
      bigger protest groups.

      "Everyone is quite convinced that it's not going to happen to them.
      It's not even hit their radar screens. Yet, from an economic
      standpoint, [secondary targeting] is far more dangerous. It is hard
      for companies to get their arms around," she says.

      Both in the UK and US, elements within the industry are convinced
      that the best defence is to be upfront with the public about the
      need, both legally and medically, to test drugs on animals.

      With big-name support on the activists' side - both Kim Basinger and
      Sir Paul McCartney endorse Peta - the establishment will need to
      pull out the stops.
    Your message has been successfully submitted and would be delivered to recipients shortly.